glp 1 mounjaro for weight loss World Health Organization issues first-ever guidelines use of GLP-1 medications Mounjaro (tirzepatide) is a dual

HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists

A double-blinded placebo-controlled phase 2 clinical study in obese patients weekly injections of mazdutide (9 mg) could cause 15.4% decreases in body weight over placebo after 24 weeks

GLP-1 Boosting Breakfasts

Buyer Trends and Structured Consumption Behavior Key consumer priorities include: Easier-to-finish meal formats High protein and nutrient density Portion control and satiety support Digestive comfort and hydration Convenient, repeatable nutrition routines Consumers are increasingly seeking practical daily-use products rather than trend-driven diet solutions